BlueStone invests in early-stage companies that operate within the Life Sciences. The Fund primarily focuses on companies that reside within five key verticals including: Medical Devices, Advanced Materials, Healthcare IT, Diagnostics, and Biopharma Platforms.
We seek companies that have developed transformative platforms or disruptive technologies, are protected by strong intellectual property, and will have a meaningful impact on healthcare. Our preference is for companies residing in the NATO States (New Mexico, Arizona, Texas, and Oklahoma), however, as a return-driven fund, we will make investments regardless of geography if they fit our “Southwest-like” metrics.
BlueStone provides growth capital and strategic support to our portfolio companies in addition to privileged access to strategic partners including investors, customers, and other partners residing within the supply chain.
Copyright 2020 © BlueStone Venture Partners